4//SEC Filing
Duty Stuart 4
Accession 0001562180-23-007327
CIK 0001314102other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:49 PM ET
Size
5.6 KB
Accession
0001562180-23-007327
Insider Transaction Report
Form 4
Duty Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-16+60,000→ 60,000 totalExercise: $8.23Exp: 2033-10-15→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in three ratable annual installments beginning on October 16, 2024.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001970274
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:49 PM ET
- Size
- 5.6 KB